Advantages of the Net Benefit Regression Framework for Trial-Based Economic Evaluations of Cancer Treatments: An Example From the Canadian Cancer Trials Group CO.17 Trial
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5779-x
Full Text
Open PDFAbstract
Available in full text
Date
June 7, 2019
Authors
Publisher
Springer Science and Business Media LLC